Principal Financial Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Principal Financial Group's TWST Position: Q2 2026 in Review
Principal Financial Group reduced its Twist Bioscience (TWST) stake by 45% in Q2 2026, selling an estimated $3.14M and leaving 58,508 shares worth $6.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.
Principal Financial Group first reported a position in TWST in Q2 2020 and has held it in 23 quarters since. The position peaked at $17.4M in Q4 2024. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Principal Financial Group held 58,508 shares of Twist Bioscience worth $6.02M as of Q2 2026.
- Principal Financial Group sold 48,204 Twist Bioscience shares in Q2 2026, an estimated $3.14M.
- Twist Bioscience made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1606 holding.
- Principal Financial Group first reported a position in Twist Bioscience in Q2 2020 and has held it in 23 quarters since.
- Principal Financial Group's Twist Bioscience position peaked at $17.4M in Q4 2024.
- 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.